authorizing pharmacists to provide certain medical devices associated with prescribed medication.
Refer to Interim Study, MA, VV; 05/14/2026; SJ 12
Summary
HB 1249 expands the definition of pharmacy practice so pharmacists can prescribe and dispense FDA‑approved devices such as inhalation spacers, nebulizers, CPAP and insulin‑pump supplies, saline, diabetes testing kits, and pen needles. The change affects pharmacists, patients, and prescribers by streamlining access to these devices, while requiring pharmacists to follow board standards and notify the original prescriber when possible. The measure aims to improve medication delivery and convenience without adding new funding or penalties.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HB 1249 changes status, plus AI-powered summaries and stage predictions.
Sign up free